• $428.5M
    Market Cap
  • 63.59%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
Income Statement
Total Operating Revenue
0
N/A
0
N/A
0
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
525,717
+40.88%
373,171
+7.86%
345,992
N/A
Research and Development Expense
-21.3M
+32.67%
-16.1M
-21.81%
-20.6M
N/A
Depreciation and Amortization Expense
237,717
+38.43%
171,719
+10.41%
155,527
N/A
Total Operating Expenses
38.4M
+42.33%
27.0M
-3.03%
27.8M
N/A
Operating Profit
-38.6M
+49.89%
-25.7M
-11.02%
-28.9M
N/A
Interest Income
1.4M
+21.77%
1.2M
+34.41%
862,969
N/A
Interest Expense
0
+100.00%
-603,573
-48.42%
-1.2M
N/A
Interest Income and Expense and Net
1.4M
+153.88%
556,370
+281.11%
-307,204
N/A
Total Nonoperating Income and Expense
-152,522
-112.10%
1.3M
+216.48%
-1.1M
N/A
Income before Taxes
-38.6M
+49.89%
-25.7M
-11.02%
-28.9M
N/A
Income Taxes
19,091
+958.26%
1,804
-95.05%
36,423
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-38.6M
+51.26%
-25.5M
-9.63%
-28.2M
N/A
Net Income from Continuing Operations Applicable to Common
-38.6M
+49.89%
-25.7M
-11.02%
-28.9M
N/A
Basic EPS and Net Income
-1.03
+35.53%
-0.76
-35.04%
-1.17
N/A
Diluted EPS and Net Income
-1.03
+35.53%
-0.76
-35.04%
-1.17
N/A
Basic Weighted Average Shares
40.0M
+17.76%
33.9M
+40.52%
24.1M
N/A
Diluted Weighted Average Shares
40.0M
+17.76%
33.9M
+40.52%
24.1M
N/A
Balance Sheet
Cash and Cash Equivalents
80.6M
+143.38%
33.1M
+71.14%
19.3M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
80.6M
+143.38%
33.1M
+71.14%
19.3M
N/A
Total Current Assets
85.1M
+147.12%
34.4M
+73.90%
19.8M
N/A
Accumulated Depreciation
88,684
+57.86%
56,180
-85.89%
398,065
N/A
Property and Plant and Equipment and Net
834,429
+133.15%
357,893
-12.62%
409,587
N/A
Total Long-Term Assets
834,429
+133.15%
357,893
-12.62%
409,587
N/A
Total Assets
86.2M
+146.55%
34.9M
+72.42%
20.3M
N/A
Income Taxes Payable
1,606
-95.59%
36,423
0.00%
36,423
N/A
Total Short-Term Debt
0
-100.00%
10.4M
0.00%
10.4M
N/A
Total Current Liabilities
5.6M
+85.65%
3.0M
-84.35%
19.4M
N/A
Total Long-Term Debt
4.6M
0.00%
4.6M
-47.98%
8.8M
N/A
Total Long-Term Liabilities
75,910
-98.44%
4.9M
+9,357.30%
51,303
N/A
Total Liabilities
5.7M
+83.80%
3.1M
-83.98%
19.4M
N/A
Retained Earnings
-169.6M
+29.45%
-131.0M
+24.17%
-105.5M
N/A
Total Stockholders Equity
82.0M
+145.60%
33.4M
+1,407.30%
2.2M
N/A
Total Shares Outstanding
51.9M
+45.73%
35.6M
+30.64%
27.3M
N/A
Cash Flow
Cash from Operating Activities
-28.6M
-4.81%
-30.0M
+45.02%
-20.7M
N/A
Capital Expenditures
588,947
+465.06%
104,227
+42.04%
73,377
N/A
Cash from Investing Activities
-588,947
+683.60%
-75,159
+2.43%
-73,377
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
76.1M
+66.12%
45.8M
+117.88%
21.0M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-63.71%
-31.04%
-92.39%
N/A
N/A
N/A
Return on Equity
-66.83%
-53.33%
-143.19%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
15.12
+33.11%
11.36
N/A
N/A
N/A
Cash Ratio
14.31
+31.10%
10.92
N/A
N/A
N/A
Debt-to-Equity Ratio
0.06
-87.56%
0.45
N/A
N/A
N/A
Debt-to-Assets Ratio
0.05
-87.59%
0.43
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow